NDC Compounded Drug 72682-3725-1 Estradiol

Pellet Subcutaneous

Table of Contents

    1. Compounded Product Information
    2. NDC Crossover Products Matching Estradiol 25mg
    3. Frequently Asked Questions

Compounded Drug Product Information

NDC Product Code 72682-3725
NDC Package Code 72682-3725-1
11-Digit NDC Billing Format NDC Format for Billing
For insurance billing purposes the Centers for Medicare & Medicaid Services (CMS) created an 11 digit NDC derivative identifier. If the NDC Package code is less than 11 digits the code must be padded with leading zeros. The leading zeros must be added to the appropriate segment to create a 5-4-2 configuration.		 72682372501
Package Description 1 mg in 1 VIAL
Product Type What kind of product is this?
Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.		 Human Compounded Drug
Proprietary Name What is the Proprietary Name?
The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.		 Estradiol 25mg
Non-Proprietary Name What is the Non-Proprietary Name?
The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.		 Estradiol 25mg
Substance Name What is the Substance Name?
An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.		 Estradiol
Usage Information Product Usage Information
The drug use information is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate. This information is not individual medical advice and does not substitute for the advice of a health care professional. Always ask a health care professional for complete information about this product and your specific health needs.		 This medication is a female hormone (estrogen). It is used by women to help reduce symptoms of menopause (such as hot flashes, vaginal dryness). These symptoms are caused by the body making less estrogen. If you are using this medication to treat symptoms only in and around the vagina, products applied directly inside the vagina should be considered before medications that are taken by mouth, absorbed through the skin, or injected. This medication may also be used by women who are not able to produce enough estrogen (for example, due to hypogonadism, primary ovarian failure). Certain estrogen products may also be used by women after menopause to prevent bone loss (osteoporosis). However, there are other medications (such as raloxifene, bisphosphonates including alendronate) that are also effective in preventing bone loss and may be safer. These medications should be considered for use before estrogen treatment.
Dosage Form Pellet - A small sterile solid mass consisting of a highly purified drug (with or without excipients) made by the formation of granules, or by compression and molding.
Route Name Subcutaneous - Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.
Marketing Category OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Code 72682
Labeler Name What is the Labeler Name?
Name of Company corresponding to the labeler code segment of the Product NDC.		 Anazaohealth Corporation
Substance Name Estradiol
Active Ingredients Information 25 mg/25 mg
Reporting Period 2023-1

NDC Crossover Products Matching Estradiol

NDC crossover of Estradiol 25mg with NDC 72682-3725 a human compounded drug with other similar products matching the same substance name (Estradiol) and the same administration route (subcutaneous) or dosage form (pellet).

Frequently Asked Questions

What is the NDC number assigned to E2 37.5mg?

E2 37.5mg was assigned by its manufacturer with NDC product code 72682-3725. This product is a drug classified as a human compounded drug. Compounded drugs are medications created by combining or altering existing drugs to meet the specific needs of certain patients. The NDC directory only includes information about compounded drugs from facilities that choose to assign NDC numbers to their products.

Which are the NDC package codes for E2 37.5mg?

The NDC package code 72682-3725-1 was assigned to a 1 mg in 1 VIAL of estradiol administered subcutaneous via pellet.

Who manufactures this product?

E2 37.5mg is manufactured by an outsourced facility and labeled by Anazaohealth Corporation. All compounded drugs included in the NDC directory are classified as "Outsourcing Facility Compounded Human Drug Product (Exempt from Approval Requirements)". Outsourcing facilities are a type of drug compounding facility regulated under Section 503B of the FD&C Act could be eligible for exemptions from drug registration if they meet all the conditions specified under Section 503B.

Which are the NDC crossover matchings for this product?

We found 30 matching products that have the same substance, dosage form and administration route. The matching products are manufactured by BSO, LLC with NDC product codes 70168-2010-1, 70168-2010-1, 70168-2010-1, 70168-2010-1, 70168-2020-1, 70168-2020-1, 70168-2020-1, 70168-2020-1, 70168-2030-1, 70168-2030-1, 70168-2030-1, 70168-2030-1, 70168-2040-1, 70168-2040-1, 70168-2040-1, 70168-2040-1, 70168-2050-1, 70168-2050-1, 70168-2050-1, 70168-2050-1, 70168-2060-1, 70168-2060-1, 70168-2060-1, 70168-2060-1, 70168-2080-1, 70168-2080-1, 70168-2080-1, 70168-2080-1, 70168-2090-1 and 70168-2090-1.